A respiratory syncytial virus replicon that is noncytotoxic and capable of long-term foreign gene expression

Journal of Virology

Volumn 85, Issue 10, 2011, Pages 4792-4801

  Malykhina, Olga ^a,b   Yednak, Mark A ^a   Collins, Peter L ^c   Olivo, Paul D ^d,e   Peeples, Mark E ^a,b  

^a THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d Apath LLC   (United States)

^e Quidel Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON;

ANIMAL CELL; ARTICLE; BLASTICIDIN S DEAMINASE GENE; CELL DIVISION; CELL FUSION; CELL GROWTH; CELL STRAIN BHK; CELL STRAIN HEK293; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; CYTOTOXICITY; GENE EXPRESSION; GLYCOPROTEIN GENE; HELA CELL; HUMAN; HUMAN CELL; INTERFERON PRODUCTION; NONHUMAN; PRIORITY JOURNAL; REPLICON; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VERO CELL; VIRUS GENE; VIRUS GENOME; VIRUS REPLICATION; VISION;

GENE DELETION; GENE EXPRESSION; GENES, VIRAL; GENETIC VECTORS; GENOMIC INSTABILITY; RECOMBINANT PROTEINS; REPLICON; RESPIRATORY SYNCYTIAL VIRUSES; VIRAL STRUCTURAL PROTEINS;

RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

EID: 79955458991     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02399-10     Document Type: Article

References (58)

1. Agapov, E. V., et al. 1998. Noncytopathic Sindbis virus RNA vectors for heterologous gene expression. Proc. Natl. Acad. Sci. U. S. A. 95:12989- 12994.
2. Baldridge, P., and L. B. Senterfit. 1976. Persistent infection of cells in culture by respiratory syncytial virus. Proc. Soc. Exp. Biol. Med. 151:684-688.
3. Ban, H., et al. 2007. Expression and maturation of Sendai virus vector-derived CFTR protein: functional and biochemical evidence using a GFP-CFTR fusion protein. Gene Ther. 14:1688-1694.
4. Barretto, N., L. K. Hallak, and M. E. Peeples. 2003. Neuraminidase treatment of respiratory syncytial virus-infected cells or virions, but not target cells, enhances cell-cell fusion and infection. Virology 313:33-43.
5. Blight, K. J., A. A. Kolykhalov, and C. M. Rice. 2000. Efficient initiation of HCV RNA replication in cell culture. Science 290:1972-1974.
6. Blight, K. J., J. A. McKeating, and C. M. Rice. 2002. Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J. Virol. 76:13001-13014.
7. Byrappa, S., D. K. Gavin, and K. C. Gupta. 1995. A highly efficient procedure for site-specific mutagenesis of full-length plasmids using Vent DNA polymerase. Genome Res. 5:404-407.
8. Cantell, K. 1961. Production and action of interferon in HeLa cells. Arch. Gesamte Virusforsch. 10:510-521.
9. Carroll, A. R., and R. R. Wagner. 1979. Role of the membrane (M) protein in endogenous inhibition of in vitro transcription by vesicular stomatitis virus. J. Virol. 29:134-142.
10. Cattaneo, R., et al. 1989. Mutated and hypermutated genes of persistent measles viruses which caused lethal human brain diseases. Virology 173:415-425.
11. Cheng, X., H. Park, H. Zhou, and H. Jin. 2005. Overexpression of the M2-2 protein of respiratory syncytial virus inhibits viral replication. J. Virol. 79: 13943-13952.
12. Collins, P. L., and B. S. Graham. 2008. Viral and host factors in human respiratory syncytial virus pathogenesis. J. Virol. 82:2040-2055.
13. Collins, P. L., et al. 1995. Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5 ' proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development. Proc. Natl. Acad. Sci. U. S. A. 92:11563-11567.
14. Dryga, S. A., O. A. Dryga, and S. Schlesinger. 1997. Identification of mutations in a Sindbis virus variant able to establish persistent infection in BHK cells: the importance of a mutation in the nsP2 gene. Virology 228:74-83.
15. Emeny, J. M., and M. J. Morgan. 1979. Regulation of the interferon system: evidence that Vero cells have a genetic defect in interferon production. J. Gen. Virol. 43:247-252.
16. Falsey, A. R., and E. E. Walsh. 2005. Respiratory syncytial virus infection in elderly adults. Drugs Aging 22:577-587.
17. Ferrari, S., et al. 2007. Sendai virus-mediated CFTR gene transfer to the airway epithelium. Gene Ther. 14:1371-1379.
18. Ferrari, S., et al. 2004. A defective nontransmissible recombinant Sendai virus mediates efficient gene transfer to airway epithelium in vivo. Gene Ther. 11:1659-1664.
19. Frolov, I., et al. 1999. Selection of RNA replicons capable of persistent noncytopathic replication in mammalian cells. J. Virol. 73:3854-3865.
20. Garcia-Barreno, B., A. Portela, T. Delgado, J. A. Lopez, and J. A. Melero. 1990. Frame shift mutations as a novel mechanism for the generation of neutralization resistant mutants of human respiratory syncytial virus. EMBO J. 9:4181-4187.
21. Ghildyal, R., J. Mills, M. Murray, N. Vardaxis, and J. Meanger. 2002. Respiratory syncytial virus matrix protein associates with nucleocapsids in infected cells. J. Gen. Virol. 83:753-757.
22. Griesenbach, U., et al. 2006. Effect of tolerance induction to immunodominant T-cell epitopes of Sendai virus on gene expression following repeat administration to lung. Gene Ther. 13:449-456.
23. Guerrero-Plata, A., E. Ortega, and B. Gomez. 2001. Persistence of respiratory syncytial virus in macrophages alters phagocytosis and pro-inflammatory cytokine production. Viral Immunol. 14:19-30.
24. Hanley, L. L., et al. 2010. Roles of the respiratory syncytial virus trailer region: effects of mutations on genome production and stress granule formation. Virology 406:241-252.
25. Hirata, T., et al. 2002. An improved method for recovery of F-defective Sendai virus expressing foreign genes from cloned cDNA. J. Virol. Methods 104:125-133.
26. Hobson, L., and M. L. Everard. 2008. Persistent of respiratory syncytial virus in human dendritic cells and influence of nitric oxide. Clin. Exp. Immunol. 151:359-366.
27. Hu, C, and K. C. Gupta. 2000. Functional significance of alternate phosphorylation in Sendai virus P protein. Virology 268:517-532.
28. Inoue, M., et al. 2003. A new Sendai virus vector deficient in the matrix gene does not form virus particles and shows extensive cell-to-cell spreading. J. Virol. 77:6419-6429.
29. Inoue, M., et al. 2003. Nontransmissible virus-like particle formation by F-deficient Sendai virus is temperature sensitive and reduced by mutations in M and HN proteins. J. Virol. 77:3238-3246.
30. Inoue, M., et al. 2004. Recombinant Sendai virus vectors deleted in both the matrix and the fusion genes: efficient gene transfer with preferable properties. J. Gene Med. 6:1069-1081.
31. Kanzaki, S., A. Shiotani, M. Inoue, M. Hasegawa, and K. Ogawa. 2007. Sendai virus vector-mediated transgene expression in the cochlea in vivo. Audiol. Neurootol. 12:119-126.
32. Kato, T., et al. 2003. Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon. Gastroenterology 125:1808-1817.
33. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
34. Levine, S. 1977. Polypeptides of respiratory syncytial virus. J. Virol. 21:427-431.
35. Lohmann, V., F. Korner, A. Dobierzewska, and R. Bartenschlager. 2001. Mutations in hepatitis C virus RNAs conferring cell culture adaptation. J. Virol. 75:1437-1449.
36. Lohmann, V., et al. 1999. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285:110-113.
37. Nishimura, K., et al. 2007. Persistent and stable gene expression by a cyto-plasmic RNA replicon based on a noncytopathic variant Sendai virus. J. Biol. Chem. 282:27383-27391.
38. Olivo, P. D., P. L. Collins, M. E. Peeples, and S. Schlesinger. 1998. Detection and quantitation of human respiratory syncytial virus (RSV) using minigenome cDNA and a Sindbis virus replicon: a prototype assay for negativestrand RNA viruses. Virology 251:198-205.
39. Oomens, A. G., K. P. Bevis, and G. W. Wertz. 2006. The cytoplasmic tail of the human respiratory syncytial virus F protein plays critical roles in cellular localization of the F protein and infectious progeny production. J. Virol. 80:10465-10477.
40. Oomens, A. G., A. G. Megaw, and G. W. Wertz. 2003. Infectivity of a human respiratory syncytial virus lacking the SH, G, and F proteins is efficiently mediated by the vesicular stomatitis virus G protein. J. Virol. 77:3785-3798.
41. Oomens, A. G., and G. W. Wertz. 2004. The baculovirus GP64 protein mediates highly stable infectivity of a human respiratory syncytial virus lacking its homologous transmembrane glycoproteins. J. Virol. 78:124-135.
42. Oomens, A. G., and G. W. Wertz. 2004. trans-Complementation allows recovery of human respiratory syncytial viruses that are infectious but deficient in cell-to-cell transmission. J. Virol. 78:9064-9072.
43. Peeples, M., and S. Levine. 1981. Characteristics of a persistent respiratory syncytial virus infection in HeLa cells. Virology 113:141-149.
44. Perez, D. R., and R. O. Donis. 1998. The matrix 1 protein of influenza A virus inhibits the transcriptase activity of a model influenza reporter genome in vivo. Virology 249:52-61.
45. Perrotta, A. T., and M. D. Been. 1991. A pseudoknot-like structure required for efficient self-cleavage of hepatitis delta virus RNA. Nature 350:434-436.
46. Pringle, C., R. P. V. Shirodaria, P. Cash, D. J. Chiswell, and P. Malloy. 1978. Initiation and maintenance of persistent infection by respiratory syncytial virus. J. Virol. 28:199-211.
47. Sastre, P., A. G. Oomens, and G. W. Wertz. 2007. The stability of human respiratory syncytial virus is enhanced by incorporation of the baculovirus GP64 protein. Vaccine 25:5025-5033.
48. Schwarze, J., D. R. O'Donnell, A. Rohwedder, and P. J. Openshaw. 2004. Latency and persistence of respiratory syncytial virus despite T cell immunity. Am. J. Respir. Crit. Care Med. 169:801-805.
49. Sumpter, R., Jr., et al. 2005. Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J. Virol. 79:2689-2699.
50. Suryanarayana, K., K. Baczko, V. ter Meulen, and R. R. Wagner. 1994. Transcription inhibition and other properties of matrix proteins expressed by M genes cloned from measles viruses and diseased human brain tissue. J. Virol. 68:1532-1543.
51. Tanaka, S., et al. 2007. Impact of deletion of envelope-related genes of recombinant Sendai viruses on immune responses following pulmonary gene transfer of neonatal mice. Gene Ther. 14:1017-1028.
52. Techaarpornkul, S., N. Barretto, and M. E. Peeples. 2001. Functional analysis of recombinant respiratory syncytial virus deletion mutants lacking the small hydrophobic and/or attachment glycoprotein gene. J. Virol. 75:6825- 6834.
53. Teng, M. N., and P. L. Collins. 1998. Identification of the respiratory syn-cytial virus proteins required for formation and passage of helper-dependent infectious particles. J. Virol. 72:5707-5716.
54. Teng, M. N., et al. 2000. Recombinant respiratory syncytial virus that does not express the NS1 or M2-2 protein is highly attenuated and immunogenic in chimpanzees. J. Virol. 74:9317-9321.
55. Ternette, N., D. Stefanou, S. Kuate, K. Uberla, and T. Grunwald. 2007. Expression of RNA virus proteins by RNA polymerase II dependent expression plasmids is hindered at multiple steps. Virol. J. 4:51.
56. Udem, S. A., and K. A. Cook. 1984. Isolation and characterization of measles virus intracellular nucleocapsid RNA. J. Virol. 49:57-65.
57. Wilkinson, T. M., G. C. Donaldson, S. L. Johnston, P. J. Openshaw, and J. A. Wedzicha. 2006. Respiratory syncytial virus, airway inflammation, and FEV1 decline in patients with chronic obstructive pulmonary disease. Am. J. Re-spir. Crit. Care Med. 173:871-876.
58. Yoshizaki, M., et al. 2006. Naked Sendai virus vector lacking all of the envelope-related genes: reduced cytopathogenicity and immunogenicity. J. Gene Med. 8:1151-1159.